Adherence to chronic hepatitis C treatment regimen: first report from a referral center in iran. - Wikidata - awgldk - TriplyDB

Adherence to chronic hepatitis C treatment regimen: first report from a referral center in iran.

Adherence to chronic hepatitis C treatment regimen: first report from a referral center in iran.

http://www.wikidata.org/entity/Q37138784

about

Epidemiology of hepatitis C virus in Iran Health state utilities associated with attributes of treatments for hepatitis C.Adherence to prescribed medications of Iranian traditional medicine in a group of patients with chronic disease.

P2860

Q26781996-96689218-0AF8-47B9-BEC1-37C1BD671303 Q36285092-9086CB84-DA54-4776-8122-CDCD918510D6 Q36646731-95E4CFB6-01BF-4807-9197-D96C809377B1

P2860

Adherence to chronic hepatitis C treatment regimen: first report from a referral center in iran.

http://www.wikidata.org/entity/Q37138784

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adherence to chronic hepatitis ...... rom a referral center in iran.

@en

Adherence to chronic hepatitis ...... rom a referral center in iran.

@nl

type

label

Adherence to chronic hepatitis ...... rom a referral center in iran.

@en

Adherence to chronic hepatitis ...... rom a referral center in iran.

@nl

prefLabel

Adherence to chronic hepatitis ...... rom a referral center in iran.

@en

Adherence to chronic hepatitis ...... rom a referral center in iran.

@nl

P1433

Q37138784-53D5FF86-5DDB-4577-AB26-3516C6B20088

P1476

Q37138784-27037EC9-8983-48DA-A40E-F9CD213AC2D4

P2093

Q37138784-66675C5C-EC61-4D35-A74E-BE99B12AE47C

Q37138784-706C4C09-2B93-426C-A93E-5F5388693889

Q37138784-AE7B7119-6057-4228-A670-DB5E435FC115

Q37138784-F123F14A-97DF-4921-B00A-50BF16AA358F

P2860

Q37138784-0AB5694B-39A5-4D33-88E2-2AF82E8458E5

Q37138784-0ADDABD9-FBC2-45E6-9B7E-5BD457E901B8

Q37138784-0E888E85-0B37-4C5F-B212-84ED8558CA67

Q37138784-182A84E0-8469-40AD-AFCB-B853BABFAEAE

Q37138784-1B7E6D0F-59A4-46B0-BEC4-A07649B25794

Q37138784-26441A73-817D-4FEC-8533-5F5079F733B5

Q37138784-267E8D85-54F3-4B2D-AB15-FCCACF49258E

Q37138784-3085A1D1-1D70-46FA-87D6-19F91EBB7BF5

Q37138784-34379811-30D0-4B77-983C-647F04E22316

Q37138784-34E9DA66-526F-4BE7-B980-C36706F3FFD7

P304

Q37138784-925E9A87-43B8-427F-B49D-F507D4B0F798

P31

Q37138784-D05A20CE-D2F1-493A-B3CD-15334169870E

P356

Q37138784-3A1112E2-F226-4C05-942D-6178118A127B

P407

Q37138784-22EDB4CE-F2E9-4D7D-8D43-D74B7F667C09

P433

Q37138784-E1933063-139D-4C28-AFAD-90EAB531681E

P478

Q37138784-0E1FD961-DE47-4941-A60A-EA36B1397BD8

P50

Q37138784-6D262A75-E83B-4DBA-BA84-78471A87A6D6

P577

Q37138784-B2D44421-6067-44C5-86DD-D077CE3A7B9B

P5875

Q37138784-F44D7E27-64E1-4AEF-887E-CC30F8EAD32F

P698

Q37138784-049AEBD9-5565-48CF-9FC0-E1BD09FD9C09

P932

Q37138784-2B43E73B-6900-4933-82C2-EDC8DDB092A1

P356

P1433

Hepatitis Monthly

P1476

Adherence to chronic hepatitis ...... rom a referral center in iran.

@en

P2093

Hossein Khalili

http://www.w3.org/2001/XMLSchema#string

Mehdi Ahadi-Barzoki

http://www.w3.org/2001/XMLSchema#string

Mohsen Nasiri Toosi

http://www.w3.org/2001/XMLSchema#string

Saeedeh Ravi

http://www.w3.org/2001/XMLSchema#string

P2860

Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: A prospective, real-life, observational study

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

Diagnosis, management, and treatment of hepatitis C: an update

The global burden of hepatitis C

Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin

P304

e11038

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5812/HEPATMON.11038

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Iman Karimzadeh

P577

2013-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256542390

http://www.w3.org/2001/XMLSchema#string

P698

24032043

http://www.w3.org/2001/XMLSchema#string

P932

3759779

http://www.w3.org/2001/XMLSchema#string